These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21325697)

  • 1. Therapy in pneumonia: what is beyond antibiotics?
    Meijvis SC; Grutters JC; Thijsen SF; Rijkers GT; Biesma DH; Endeman H
    Neth J Med; 2011 Jan; 69(1):21-6. PubMed ID: 21325697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia in adults: initial antibiotic therapy.
    King DE; Pippin HJ
    Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia.
    Daneman N; Low DE; McGeer A; Green KA; Fisman DN
    Clin Infect Dis; 2008 Apr; 46(8):1131-8. PubMed ID: 18444846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short course antibiotherapies in community-acquired pneumonia].
    Bulbul Y; Ozlu T
    Tuberk Toraks; 2008; 56(3):344-52. PubMed ID: 18932039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment of community-acquired pneumonia.
    Liapikou A; Torres A
    Expert Opin Pharmacother; 2013 Jul; 14(10):1319-32. PubMed ID: 23663104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia.
    Arnold F; LaJoie A; Marrie T; Rossi P; Blasi F; Luna C; Fernandez P; Porras J; Weiss K; Feldman C; Rodríguez E; Levy G; Arteta F; Roig J; Rello J; Ramirez J;
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):739-43. PubMed ID: 16848334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.
    Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; Janknegt R; Verheij TJ; Sachs AP; Prins JM; ;
    Neth J Med; 2012 Mar; 70(2):90-101. PubMed ID: 22418758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of pneumonia acquired in the community].
    Waschbisch T; Schlesser M; Nati R
    Bull Soc Sci Med Grand Duche Luxemb; 2002; (2):121-34. PubMed ID: 12664656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with anti-inflammatory drugs in community-acquired pneumonia.
    Meijvis SC; van de Garde EM; Rijkers GT; Bos WJ
    J Intern Med; 2012 Jul; 272(1):25-35. PubMed ID: 22583070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.
    Murcia JM; González-Comeche J; Marín A; Barberán J; Granizo JJ; Aguilar L; González-Moreno J; González-Pina B; López-Dupla M; Irurzun J;
    Clin Microbiol Infect; 2009 Nov; 15(11):1046-50. PubMed ID: 19548926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.
    Yu KT; Wyer PC
    Ann Emerg Med; 2008 May; 51(5):651-62, 662.e1-2. PubMed ID: 18272253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hanschmann A; Marre R; Suttorp N; Welte T;
    J Antimicrob Chemother; 2009 Jul; 64(1):159-62. PubMed ID: 19403654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in antibiotic therapy for community-acquired pneumonia.
    Viasus D; Garcia-Vidal C; Carratalà J
    Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of childhood pneumonia.
    Nascimento-Carvalho CM
    Expert Opin Pharmacother; 2010 Feb; 11(2):225-31. PubMed ID: 20088744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel targets in the management of pneumonia.
    Díaz LA; Mortensen EM; Anzueto A; Restrepo MI
    Ther Adv Respir Dis; 2008 Dec; 2(6):387-400. PubMed ID: 19124384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics for community-acquired pneumonia.
    Dryden M; Hand K; Davey P;
    J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.
    Li JZ; Winston LG; Moore DH; Bent S
    Am J Med; 2007 Sep; 120(9):783-90. PubMed ID: 17765048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.